Circulating markers of inflammation are related to carotid artery atherosclerosis
- PMID: 15876998
Circulating markers of inflammation are related to carotid artery atherosclerosis
Abstract
Aim: The role of inflammation in atherothrombotic disorders is becoming increasingly recognized. The present study prospectively investigates relationships between inflammatory markers and hemostatic variables, and non-invasive measures of carotid artery atherosclerosis.
Methods: Markers of hemostasis (sP-selectin and fibrinogen), cytokines (IL-6, IL-8, TNF-a and MCP-1), inflammatory variables (hsCRP, SAA and calprotectin) and cell adhesion molecules (ICAM-1 and VCAM-1) as well as ultrasonography of the carotid arteries were assessed in 111 consecutive outpatients with manifest or suspected coronary artery disease (CAD).
Results: Thirty-eight patients with manifest cardiovascular disease had higher IL-6 (P < 0.01) but not hsCRP levels. Higher levels of IL-6, calprotectin and VCAM-1 (all P < 0.05) were found in 35 patients with carotid plaques. In the whole study population (n = 109) an increased common carotid artery lumen diameter (LD) and cross sectional intima-media area (CIMA) was related to higher IL-6, IL-8 and MCP-1 levels (all P < 0.05), and increased LD also to higher hsCRP, calprotectin (both P < 0.05), sP-selectin and fibrinogen levels (both P < 0.01). Both LD and CIMA were related to VCAM-1 (both P < 0.01), but not to ICAM-1 levels. The intima-media thickness of the carotid artery was only positively related to MCP-1 levels (P < 0.05). Only the relation between IL-6 and LD remained significant after adjustment for age, gender, body mass index, smoking status or present lipid-lowering treatment.
Conclusions: Several biomarkers of inflammation are related to ultrasonographic measures of carotid artery atherosclerosis in patients with moderate to high prevalence of CAD. IL-6 seems to be an independent and useful biomarker of atherosclerosis in this group of patients.
Similar articles
-
Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).Atherosclerosis. 2006 Dec;189(2):414-9. doi: 10.1016/j.atherosclerosis.2005.12.026. Epub 2006 Jan 24. Atherosclerosis. 2006. PMID: 16438977
-
Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris.Eur Heart J. 2001 Jan;22(1):62-72. doi: 10.1053/euhj.1999.2006. Eur Heart J. 2001. PMID: 11133211 Clinical Trial.
-
Circulating adhesion molecules are correlated with ultrasonic assessment of carotid plaques.Clin Sci (Lond). 2003 May;104(5):521-7. doi: 10.1042/CS20020290. Clin Sci (Lond). 2003. PMID: 12570870
-
Carotid artery disease and stroke in patients with peripheral arterial disease. The role of inflammation.Monaldi Arch Chest Dis. 2009 Mar;72(1):10-7. doi: 10.4081/monaldi.2009.337. Monaldi Arch Chest Dis. 2009. PMID: 19645207 Review.
-
Circulating markers of inflammation and atherosclerosis.Atherosclerosis. 2003 Aug;169(2):203-14. doi: 10.1016/s0021-9150(03)00012-1. Atherosclerosis. 2003. PMID: 12921971 Review.
Cited by
-
The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people.Mol Med. 2007 Jul-Aug;13(7-8):388-95. doi: 10.2119/2007–00045.Giacconi. Mol Med. 2007. PMID: 17622311 Free PMC article.
-
An Evaluation of Plasma TNF, VEGF-A, and IL-6 Determination as a Risk Marker of Atherosclerotic Vascular Damage in Early-Onset CAD Patients.J Clin Med. 2024 Mar 18;13(6):1742. doi: 10.3390/jcm13061742. J Clin Med. 2024. PMID: 38541966 Free PMC article.
-
Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus.Int J Mol Sci. 2022 Oct 20;23(20):12604. doi: 10.3390/ijms232012604. Int J Mol Sci. 2022. PMID: 36293458 Free PMC article. Review.
-
Serum Calprotectin Level Is Independently Associated With Carotid Plaque Presence in Patients With Psoriatic Arthritis.Front Med (Lausanne). 2022 Jul 8;9:932696. doi: 10.3389/fmed.2022.932696. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35872782 Free PMC article.
-
Tocilizumab in the treatment of rheumatoid arthritis and beyond.Drug Des Devel Ther. 2014 Mar 28;8:349-64. doi: 10.2147/DDDT.S41437. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24729685 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous